| Financial Ratios | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Return on Equity | -6.003 | - | - | - |
| Net Profit Margin | -26.899 | -28.985 | -12.031 | -43.773 |
| Debt to Asset Ratio | 25.354 | - | - | - |
| Cash Ratio | 271.488 | - | - | - |
| Quick Ratio | 357.673 | - | - | - |
| Current Ratio | 400.031 | - | - | - |
Y-mAbs Therapeutics, Inc. (YMAB)
Y-mAbs Therapeutics, Inc. (YMAB)